Literature DB >> 17442609

Prevalence of cervical dystonia and spasmodic torticollis in the United States general population.

J Jankovic1, J Tsui, C Bergeron.   

Abstract

PURPOSE: To examine the prevalence of cervical dystonia (CD) in the US population.
METHOD: A survey consisting of relevant demographic and CD-related questions was e-mailed to 2 million people selected from the Shopper's Voice database.
RESULTS: Across a census-weighted sample, 0.280% of 60,062 respondents (79% female, 92% Caucasian) reported a diagnosis of CD and 0.170% reported a diagnosis of ST, indicating possible prevalence of 0.390% of either/both diagnoses. Less than half (42.7%) of those who reported either diagnosis were receiving treatment.
CONCLUSIONS: CD is potentially under-diagnosed and under-treated; approaches to increase awareness of CD and its treatments are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17442609     DOI: 10.1016/j.parkreldis.2007.02.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  33 in total

1.  BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm.

Authors:  Vasileios Siokas; Dimitrios Kardaras; Athina-Maria Aloizou; Ioannis Asproudis; Konstadinos G Boboridis; Eleni Papageorgiou; Georgios M Hadjigeorgiou; Evangelia E Tsironi; Efthimios Dardiotis
Journal:  Neuromolecular Med       Date:  2018-12-05       Impact factor: 3.843

2.  Diagnostic Delays in Spasmodic Dysphonia: A Call for Clinician Education.

Authors:  Francis X Creighton; Edie Hapner; Adam Klein; Ami Rosen; Hyder A Jinnah; Michael M Johns
Journal:  J Voice       Date:  2015-04-11       Impact factor: 2.009

3.  Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.

Authors:  A R Bentivoglio; E Di Stasio; D Mulas; M L Cerbarano; T Ialongo; A Laurienzo; Martina Petracca
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

Review 4.  Diagnosis of dystonic syndromes--a new eight-question approach.

Authors:  Kelly L Bertram; David R Williams
Journal:  Nat Rev Neurol       Date:  2012-03-20       Impact factor: 42.937

Review 5.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

6.  Clinical Characteristics and Response to Long-Term Botulinum Toxin Type A Therapy in Patients with Cervical Dystonia at a Neurology Clinic.

Authors:  Aysu Şen; Aysun Soysal; Baki Arpaci
Journal:  Noro Psikiyatr Ars       Date:  2014-12-01       Impact factor: 1.339

Review 7.  Botulinum toxin type A therapy for cervical dystonia.

Authors:  Mafalda Castelão; Raquel E Marques; Gonçalo S Duarte; Filipe B Rodrigues; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2017-12-12

Review 8.  Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Authors:  Gonçalo S Duarte; Mafalda Castelão; Filipe B Rodrigues; Raquel E Marques; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-26

9.  Acupuncture as Adjuvant Therapy for the Management of Cervical Dystonia.

Authors:  Danny Bega; Kelley Park; Ania Grimone; Fang Lin; Melinda Ring
Journal:  Med Acupunct       Date:  2018-08-01

10.  Predictive factors of outcome in cervical dystonia following deep brain stimulation: an individual patient data meta-analysis.

Authors:  Xing Hua; Bohan Zhang; Zhicheng Zheng; Houyou Fan; Linfeng Luo; Xiaosi Chen; Jian Duan; Dongwei Zhou; Meihua Li; Tao Hong; Guohui Lu
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.